Plantar Fasciitis Clinical Trials 2023

Plantar Fasciitis Clinical Trials 2023

Plantar Fasciitis research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in plantar fasciitis clinical trials today.

Plantar Fasciitis Clinical Trials

Here are the 6 most popular medical studies for plantar fasciitis

Popular filter options for plantar fasciitis trials

Plantar Fibroma Clinical Trials

View 6 Plantar Fibroma medical studies.

Plantar Fasciitis Clinical Trials With No Placebo

View 18 plantar fasciitis medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to plantar fasciitis

What are the top hospitals conducting plantar fasciitis research?

Plantar fasciitis, a common and often debilitating condition that affects the feet, is being actively addressed by top hospitals across the United States. In Winston-Salem, Wake Forest University Health Sciences takes the lead with their ongoing clinical trial dedicated to plantar fasciitis. This groundbreaking study marks their first recorded trial in 2023, showcasing their commitment to finding effective treatment options for this condition. Meanwhile, Madigan Army Medical Center in Tacoma is also making strides with an active plantar fasciitis trial and a history of one completed study since initiating their research efforts in 2022.

In Salt Lake City, the VA Salt Lake City Health Care System joins these pioneering institutions with an ongoing clinical trial targeting plantar fasciitis. Their dedication to understanding this condition began in 2022 and underscores their commitment to improving patient outcomes.

The UF Health Orthopaedics and Sports Medicine Institute located in Gainesville has similarly undertaken an active plantar fasciitis trial alongside its counterparts nationwide. With its inaugural investigation launched in 2022, they are helping pave the way toward potential breakthroughs for those suffering from this painful foot ailment.

Last but not least is New york's Hospital for Special Surgery which stands out within this group of esteemed hospitals. They have already made significant contributions through their comprehensive approach towards addressing plantar fasciitis. Having initiated a clinical trial as early as 2020 specifically tailored towards this condition, they continue to explore innovative treatments that may alleviate pain and improve quality of life for patients.

These progressive initiatives reflect how medical professionals are working tirelessly across multiple locations to tackle plantar fasciitis head-on while expanding our understanding of its causes and developing novel interventions that can provide hope for individuals grappling with this challenging foot disorder.

Which are the best cities for plantar fasciitis clinical trials?

When it comes to plantar fasciitis clinical trials, several cities show promising research opportunities. Tacoma, Washington leads the way with 2 active trials examining treatments like The Usual Care + PBM Group and Custom PFO orthosis. Winston-Salem, North carolina follows closely behind with 1 ongoing trial focused on corticosteroid injection/local anesthetic (CSI/LA). Salt Lake City, Utah and Gainesville, Florida also contribute to the advancement of knowledge in this field with 1 active trial each exploring Botulinum Toxin A and Control Cohort interventions respectively. Additionally, New york, New York joins the ranks with its own ongoing study investigating control methods for this condition. These cities offer individuals suffering from plantar fasciitis access to innovative clinical trials that may lead to improved treatment options and better outcomes.

Which are the top treatments for plantar fasciitis being explored in clinical trials?

Plantar fasciitis, a common condition causing heel pain, is the focus of ongoing clinical trials exploring potential treatments. Two notable contenders in these studies are Botulinum Toxin A and Control Cohort. Both have one active trial dedicated to plantar fasciitis and were first listed in 2022. As researchers delve deeper into their efficacy, they hold promise for providing relief to individuals suffering from this painful foot ailment.

What are the most recent clinical trials for plantar fasciitis?

Exciting progress is being made in the field of plantar fasciitis research, as recent clinical trials offer promising insights into its treatment. One notable trial explores the effectiveness of corticosteroid injection/local anesthetic (CSI/LA) for managing this condition. Another study focuses on Botulinum Toxin A and its potential therapeutic benefits, with phases 2 and 3 already completed. Additionally, a phase 2 trial examines AbobotulinumtoxinA 300 UNT as a possible treatment option. While these trials showcase advancements in plantar fasciitis management, it's important to note that regenerative injection therapy has been available since May 2011 but continues to be explored further through a phase 4 trial. These developments provide hope for individuals suffering from plantar fasciitis and pave the way for improved care strategies moving forward

What plantar fasciitis clinical trials were recently completed?

Recently completed clinical trials have shed light on the treatment of plantar fasciitis, a common and painful foot condition. These studies have provided valuable insights into potential therapeutic approaches for this ailment. Efforts led by prominent researchers and institutions have yielded noteworthy results in our quest to alleviate plantar fasciitis symptoms. Stay tuned for more comprehensive information regarding these groundbreaking trials as we strive to better understand and effectively address this debilitating condition affecting countless individuals worldwide.